Results
|
|
1621.
|
|
|
|
1622.
|
Stem cell transplantation for metastatic breast cancer: analysis of tumor contamination. [electronic resource] by
- Stadtmauer, E A
- Tsai, D E
- Sickles, C J
- Mick, R
- Luger, S M
- Porter, D L
- Mangan, P A
- Schuchter, L M
- Schuster, S J
- Loh, E Y
- Magee, D A
- Sachs, R A
- Wall, M E
- Moore, J
- Buzby, G P
- Zaleta, E
- Kamoun, M
- Silberstein, L E
Producer: 20000204
In:
Medical oncology (Northwood, London, England) vol. 16
Availability: No items available.
|
|
|
1623.
|
|
|
|
1624.
|
Prospective study of bone marrow infiltration in aggressive lymphoma by three independent methods: whole-body MRI, PET/CT and bone marrow biopsy. [electronic resource] by
- Ribrag, Vincent
- Vanel, Daniel
- Leboulleux, Sophie
- Lumbroso, Jean
- Couanet, Dominique
- Bonniaud, Guillaume
- Aupérin, Anne
- Masson, Florence
- Bosq, Jacques
- Edeline, Véronique
- Fermé, Christophe
- Pigneur, Frédéric
- Schlumberger, Martin
Producer: 20080919
In:
European journal of radiology vol. 66
Availability: No items available.
|
|
|
1625.
|
Clinical outcome of gastric cancer patients with bone marrow metastases. [electronic resource] by
- Kim, Hyo Song
- Yi, Seong Yoon
- Jun, Hyun Jung
- Lee, Jeeyun
- Park, Joon Oh
- Park, Young Suk
- Jang, Junho
- Kim, Hee-Jin
- Ko, Younghyeh
- Lim, Ho Yeong
- Kang, Won Ki
Producer: 20080522
In:
Oncology vol. 73
Availability: No items available.
|
|
|
1626.
|
Incidence of therapy-related myeloid neoplasia after initial therapy for chronic lymphocytic leukemia with fludarabine-cyclophosphamide versus fludarabine: long-term follow-up of US Intergroup Study E2997. [electronic resource] by
- Smith, Mitchell R
- Neuberg, Donna
- Flinn, Ian W
- Grever, Michael R
- Lazarus, Hillard M
- Rowe, Jacob M
- Dewald, Gordon
- Bennett, John M
- Paietta, Elisabeth M
- Byrd, John C
- Hussein, Mohamad A
- Appelbaum, Frederick R
- Larson, Richard A
- Litzow, Mark R
- Tallman, Martin S
Producer: 20111202
In:
Blood vol. 118
Availability: No items available.
|
|
|
1627.
|
The Jak2 inhibitor, G6, alleviates Jak2-V617F-mediated myeloproliferative neoplasia by providing significant therapeutic efficacy to the bone marrow. [electronic resource] by
- Kirabo, Annet
- Park, Sung O
- Majumder, Anurima
- Gali, Meghanath
- Reinhard, Mary K
- Wamsley, Heather L
- Zhao, Zhizhuang Joe
- Cogle, Christopher R
- Bisht, Kirpal S
- Keserü, György M
- Sayeski, Peter P
Producer: 20120402
In:
Neoplasia (New York, N.Y.) vol. 13
Availability: No items available.
|
|
|
1628.
|
|
|
|
1629.
|
|
|
|
1630.
|
|
|
|
1631.
|
|
|
|
1632.
|
|
|
|
1633.
|
|
|
|
1634.
|
|
|
|
1635.
|
|
|
|
1636.
|
|
|
|
1637.
|
|
|
|
1638.
|
|
|
|
1639.
|
|
|
|
1640.
|
|